综合服务费

Search documents
通策医疗收盘上涨1.31%,滚动市盈率40.53倍,总市值207.59亿元
Sou Hu Cai Jing· 2025-08-20 10:33
序号股票简称PE(TTM)PE(静)市净率总市值(元)9通策医疗40.5341.404.93207.59亿行业平均 49.2160.714.32200.77亿行业中值65.6568.373.3371.97亿1药明康德19.6828.684.522710.39亿2康龙化成 28.4529.643.79531.50亿3爱尔眼科33.3134.725.651234.68亿4诺禾致源33.7733.902.6066.72亿5普蕊斯 33.7928.932.6130.79亿6华康洁净36.7452.942.0535.37亿7诺思格36.9537.752.8452.93亿8凯莱英 38.2740.072.21380.21亿10华厦眼科41.1140.512.94173.63亿11万邦医药45.3935.922.0530.73亿12昭衍新药 60.24315.072.88233.39亿 来源:金融界 截至2025年一季报,共有16家机构持仓通策医疗,其中基金16家,合计持股数1141.44万股,持股市值 4.71亿元。 通策医疗股份有限公司的主营业务是口腔医疗服务的提供、研发。公司的主要产品是医疗服务、产品销 售、建筑工程 ...
通策医疗收盘下跌2.09%,滚动市盈率39.29倍,总市值201.24亿元
Sou Hu Cai Jing· 2025-08-14 12:38
Company Overview - Tongce Medical closed at 44.99 yuan, down 2.09%, with a rolling PE ratio of 39.29 times and a total market value of 20.124 billion yuan [1] - The company specializes in dental medical services and research, with main products including medical services, product sales, construction engineering, and comprehensive service fees [1] Financial Performance - For Q1 2025, Tongce Medical reported operating revenue of 745 million yuan, a year-on-year increase of 5.11%, and a net profit of 184 million yuan, up 6.22%, with a gross profit margin of 44.21% [1] Industry Comparison - The average PE ratio for the medical services industry is 49.00 times, with a median of 62.63 times, placing Tongce Medical at 24th in the industry ranking [1][2] - The total market value of the industry averages 20.418 billion yuan, with the median at 70.65 billion yuan [2] Institutional Holdings - As of Q1 2025, 16 institutions hold shares in Tongce Medical, all being funds, with a total holding of 11.4144 million shares valued at 471 million yuan [1]
通策医疗收盘上涨1.50%,滚动市盈率40.73倍,总市值208.62亿元
Sou Hu Cai Jing· 2025-07-29 10:25
Company Overview - Tongce Medical's closing price on July 29 was 46.64 yuan, with an increase of 1.50%, resulting in a rolling price-to-earnings (PE) ratio of 40.73 times and a total market capitalization of 20.862 billion yuan [1] - The company's main business is providing and researching oral medical services, with key products including medical services, product sales, construction engineering, and comprehensive service fees [1] Financial Performance - For the first quarter of 2025, Tongce Medical reported operating revenue of 745 million yuan, a year-on-year increase of 5.11%, and a net profit of 184 million yuan, up 6.22% year-on-year, with a gross profit margin of 44.21% [1] Shareholder Information - As of May 28, 2025, Tongce Medical had 83,145 shareholders, a decrease of 1,346 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical services industry is 48.95 times, with a median of 60.06 times, placing Tongce Medical at the 23rd position within the industry [2] - The industry average market capitalization is 20.44 billion yuan, while the median is 66.76 billion yuan [2]
通策医疗收盘上涨10.01%,滚动市盈率41.45倍,总市值212.33亿元
Sou Hu Cai Jing· 2025-07-24 10:50
Company Overview - Tongce Medical closed at 47.47 yuan, up 10.01%, with a rolling PE ratio of 41.45, marking a new low in 87 days, and a total market capitalization of 21.233 billion yuan [1] - The company's main business is providing oral medical services and research, with key products including medical services, product sales, construction engineering, and comprehensive service fees [1] Financial Performance - For Q1 2025, Tongce Medical reported operating revenue of 745 million yuan, a year-on-year increase of 5.11%, and a net profit of 184 million yuan, up 6.22% year-on-year, with a gross profit margin of 44.21% [1] Industry Comparison - The average PE ratio for the medical services industry is 46.96, with a median of 54.55, placing Tongce Medical at 26th in the industry ranking [2] - The company has 16 institutional holders, all of which are funds, holding a total of 11.4144 million shares valued at 471 million yuan [1]
通策医疗收盘上涨1.69%,滚动市盈率37.31倍,总市值191.13亿元
Sou Hu Cai Jing· 2025-07-18 10:40
Group 1 - The core viewpoint of the articles highlights the performance and valuation of Tongce Medical, which closed at 42.73 yuan, marking a 1.69% increase, with a rolling PE ratio of 37.31, the lowest in 65 days, and a total market capitalization of 19.113 billion yuan [1][2] - In comparison to the industry, Tongce Medical's PE ratio of 37.31 is below the average of 44.90 and the median of 45.97 for the medical services sector, ranking 25th among its peers [1][2] - As of the first quarter of 2025, 10 institutions hold shares in Tongce Medical, with a total of 9.1247 million shares valued at 377 million yuan [1] Group 2 - Tongce Medical specializes in oral medical services, including the provision of medical services, product sales, construction engineering, and comprehensive service fees [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 745 million yuan, a year-on-year increase of 5.11%, and a net profit of 184 million yuan, up 6.22%, with a gross profit margin of 44.21% [1]
通策医疗收盘上涨1.50%,滚动市盈率36.61倍,总市值187.50亿元
Sou Hu Cai Jing· 2025-07-16 10:22
Group 1 - The core viewpoint of the articles highlights the performance and valuation of Tongce Medical, which closed at 41.92 yuan with a rolling PE ratio of 36.61, marking a new low in 25 days, and a total market capitalization of 18.75 billion yuan [1] - The average PE ratio for the medical services industry is 43.29, with a median of 47.24, positioning Tongce Medical at the 25th rank within the industry [1][2] - As of May 28, 2025, the number of shareholders in Tongce Medical is 83,145, a decrease of 1,346 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Tongce Medical specializes in providing oral medical services and research, with its main products including medical services, product sales, construction engineering, and comprehensive service fees [1] - In the latest quarterly report for Q1 2025, the company achieved a revenue of 745 million yuan, reflecting a year-on-year growth of 5.11%, and a net profit of 184 million yuan, with a year-on-year increase of 6.22%, and a sales gross margin of 44.21% [1]
通策医疗收盘上涨1.34%,滚动市盈率35.58倍,总市值182.23亿元
Sou Hu Cai Jing· 2025-06-24 12:22
Group 1 - The core viewpoint of the articles highlights the performance and valuation of Tongce Medical, which closed at 40.74 yuan with a PE ratio of 35.58 times, and a total market capitalization of 18.223 billion yuan [1][2] - The average PE ratio for the medical services industry is 39.95 times, with a median of 41.77 times, positioning Tongce Medical at the 26th rank within the industry [1][2] - As of the first quarter of 2025, 21 institutions hold shares in Tongce Medical, including 18 funds, with a total holding of 209.5898 million shares valued at 9.488 billion yuan [1] Group 2 - Tongce Medical's main business focuses on providing oral medical services and research, with key products including medical services, product sales, construction engineering, and comprehensive service fees [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 745 million yuan, representing a year-on-year increase of 5.11%, and a net profit of 184 million yuan, up by 6.22%, with a gross profit margin of 44.21% [1]
通策医疗收盘下跌1.43%,滚动市盈率35.47倍,总市值181.69亿元
Sou Hu Cai Jing· 2025-05-16 10:39
Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Tongce Medical, which operates in the dental healthcare sector [1][2] - As of May 16, Tongce Medical's closing price was 40.62 yuan, with a decline of 1.43%, resulting in a rolling PE ratio of 35.47 times and a total market capitalization of 18.169 billion yuan [1] - The average PE ratio for the healthcare services industry is 37.33 times, with a median of 39.22 times, positioning Tongce Medical at 26th place within the industry [1][2] Group 2 - As of the first quarter of 2025, 21 institutions held shares in Tongce Medical, including 18 funds, with a total holding of 209.5898 million shares valued at 9.488 billion yuan [1] - The main business of Tongce Medical includes providing dental healthcare services and research, with key products being medical services, product sales, construction engineering, and comprehensive service fees [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 745 million yuan, a year-on-year increase of 5.11%, and a net profit of 184 million yuan, reflecting a year-on-year growth of 6.22%, with a gross profit margin of 44.21% [1]